Replies to post #30299 on Rock Creek Pharmaceuticals Inc. (fka RCPIQ)

[knuts4oe]

MYMD PHARMA PART 3 "ABOUT US"

"In vitro and in vivo murine model studies have demonstrated that without measurable toxicity, MYMD-1:
Regulates Th1 and the release of TNF-a in a dose dependent manner
Ameliorates autoimmune thyroiditis
Prevents and reverses multiple sclerosis
Improves vital health signs
Reverses aging, as measured by key markers for cellular aging and by murine longevity studies."

Jonnie Williams has applied for numerous US and World patents including the latest published 2020-02-27, Entitled "Pharmaceutical Salts of Isomyosmine And Pharmaceutical Compositions Containing Same" which is a mind blower. Check Google Patents for US20200061043A1.